Proton pump inhibitor prescribing following Endoscopic diagnosis in a district general hospital

C.E. Curtis, N. Ford, J.F. Marriott, K.A. Wilson, C.A. Langley

Research output: Contribution to journalConference abstractpeer-review

Abstract

Focal points:
A systematic review of the use of proton pump inhibitors was conducted among patients undergoing diagnostic fibreoptic endoscopic examination of the upper gastrointestinal tract during the period July 2001 to February 2002 inclusive
A total of 2,557 patients received a PPI following endoscopy and healing doses were prescribed to 75.3 per cent of these patients
An “unknown indication” was stated as a diagnosis in 958 patients (37.5 per cent) of patients studied
Although endoscopic diagnosis does not appear possible in all cases, the present study demonstrates that NICE guidance to employ the lowest appropriate dose of PPI is followed
Original languageEnglish
Pages (from-to)R41
Number of pages1
JournalInternational Journal of Pharmacy Practice
Volume10
Issue numberS1
DOIs
Publication statusPublished - Sept 2002
EventBritish Pharmaceutical Conference 2002 - Manchester, United Kingdom
Duration: 23 Sept 200225 Sept 2002

Fingerprint

Dive into the research topics of 'Proton pump inhibitor prescribing following Endoscopic diagnosis in a district general hospital'. Together they form a unique fingerprint.

Cite this